$MRK Company News Three investments to own and three to

New Post Public Reply Private Reply Replies (0) Message Board

Jan 13, 2015 at 11:02 AM

$MRK Company News

Three investments to own and three to 6:00 a.m. Today - Howard Gold
Bristol-Myers Squibb jumps on Opdivo cancer drug test 8:17 a.m. Jan. 12, 2015 - Angela Chen
Here are the best-performing stocks so far in 2015 11:47 a.m. Jan. 9, 2015 - Philip van Doorn
Ebola vaccines ready for West Africa tests: WHO 11:11 a.m. Jan. 9, 2015 - MarketWatch.com
Health-care sector taking a broad beating as pricing fears grow 2:39 p.m. Dec. 23, 2014 - Tomi Kilgore
FDA approves Bristol-Myers’s skin cancer treatment Opdivo 6:09 p.m. Dec. 22, 2014 - Ron Winslow
Nike slips after hours as orders fail to impress 6:38 p.m. Dec. 18, 2014 - MarketWatch
Merck acquires OncoEthix for up to $375 million 8:41 a.m. Dec. 18, 2014 - Angela Chen
From China to the U.S., a surreal week in business news 9:28 a.m. Dec. 12, 2014 - Marek Fuchs
Human trial of experimental Merck Ebola vaccine is suspended 2:17 p.m. Dec. 11, 2014 - Jeanne Whalen
Restoration Hardware shares jump on earnings beat 6:46 p.m. Dec. 10, 2014 - MarketWatch
Merck drug shrank tumors in some breast cancer patients in trial 8:57 a.m. Dec. 10, 2014 - Peter Loftus
Here are today’s biggest S&P 500 losers ... and five winners 12:51 p.m. Dec. 9, 2014 - Philip van Doorn
H&R Block shares fall on quarterly miss 6:41 p.m. Dec. 8, 2014 - Sue Chang
The S&P 500 recorded its biggest drop in nearly 7 weeks 4:33 p.m. Dec. 8, 2014 - Sara Sjolin
Russell 2000 rattles cage on major resistance 11:15 a.m. Dec. 8, 2014 - Michael Ashbaugh
Dow 18,000 beckons, but a bottom in oil prices does not 7:42 a.m. Dec. 8, 2014 - Shawn Langlois
Newscast: Oil prices plunge 7:38 a.m. Dec. 8, 2014 - MarketWatch
Merck to buy Cubist Pharmaceuticals for $8.4 billion 7:26 a.m. Dec. 8, 2014 - Peter Loftus
Merck to buy Cubist Pharmaceuticals in $9.5 billion deal 7:13 a.m. Dec. 8, 2014 - Tomi Kilgore

Lilly to Collaborate on Cancer Drug Trials 8:52 a.m. Today - The Wall Street Journal Interactive Edition
Lilly and Merck team up in cancer trials 8:44 a.m. Today - Seeking Alpha
Agenus Soars on Immuno-Oncology Agreement with Incyte - Analyst Blog 6:45 p.m. Jan. 12, 2015 - Zacks.com
Bristol’s Lung Cancer Drug Aces Trial, Cheers Bulls 3:13 p.m. Jan. 12, 2015 - Barrons.com
Bristol-Myers Hits 14-Year High On Cancer Drug Trial 1:25 p.m. Jan. 12, 2015 - Investors Business Daily
I'm Expecting Some Very Positive News Flow From Gilead 11:55 a.m. Jan. 12, 2015 - Seeking Alpha
Dow Jones (DJIA) Today: Merck (MRK) Leads The Day Higher, Chevron (CVX) Lags 10:00 a.m. Jan. 12, 2015 - TheStreet.com
Bristol-Myers’s Lung Cancer Drug Shows Success 9:32 a.m. Jan. 12, 2015 - The Wall Street Journal Interactive Edition
Merck to Continue Focus on Cancer Drug Keytruda 8:02 a.m. Jan. 12, 2015 - The Wall Street Journal Interactive Edition
5 Biotech Stocks With Explosive Drug Pipelines 8:01 a.m. Jan. 12, 2015 - InvestorPlace.com
Merck (MRK) Stock Higher Today as It Speeds Plans to Submit New Drugs 7:52 a.m. Jan. 12, 2015 - TheStreet.com
Merck accelerates regulatory submission plans in cancer and hepatitis 7:13 a.m. Jan. 12, 2015 - Seeking Alpha
Bristol-Myers Checkpoint Inhibitor Prolongs Lung Cancer Patient Survival 7:07 a.m. Jan. 12, 2015 - TheStreet.com
January 12 Premarket Briefing: 10 Things You Should Know 7:03 a.m. Jan. 12, 2015 - TheStreet.com
Merck & Co., Inc. (MRK): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report 7:00 a.m. Jan. 12, 2015 - Zacks.com
Merck Accelerates Drug-Submission Plans 11:04 p.m. Jan. 11, 2015 - The Wall Street Journal Interactive Edition
Bristol-Myers stops cancer trial early after Opdivo meets efficacy endpoint 10:29 p.m. Jan. 11, 2015 - Seeking Alpha
Ebola Vaccines Ready for West Africa Tests This Month, Says WHO 11:05 a.m. Jan. 9, 2015 - The Wall Street Journal Interactive Edition
The Bullish and Bearish Case for Pfizer in 2015 10:37 a.m. Jan. 9, 2015 - 247WallSt.com
Hall of Fame/ Hall of Shame: The Best and Worst Recommendations of 2014 9:25 a.m. Jan. 9, 2015 - GuruFocus.com

Vista Partners Initiates Coverage on OncoSec Medical (Ticker: ONCS); Price Target $1.20 9:02 a.m. Today - Marketwired
Lilly, Merck Enter Collaboration Agreement to Research Immuno-Oncology Combination Regimens in Multiple Types of Cancer 8:01 a.m. Today - BusinessWire - BZX
Moderna Announces License and Collaboration Agreement with Merck to Develop Messenger RNA-based Antiviral Vaccines and Passive Immunity Therapies 8:00 a.m. Today - PR Newswire - PRF
Neviah Genomics Achieves Key Development Milestone for PropheTox™ Bioassay for Early Prediction of Drug-Induced Liver Toxicity and Secures Additional Financing 7:00 a.m. Jan. 12, 2015 - BusinessWire - BZX
Adimab Announces New Partnerships with Acceleron, Oncothyreon, Surface Oncology and Potenza 9:45 a.m. Jan. 9, 2015 - BusinessWire - BZX
Beverage Industry Exec Ken Sadowsky Joins Theocorp Advisory Board 8:30 a.m. Jan. 9, 2015 - PR Newswire - PRF
Merck to Present at the 33rd Annual J.P. Morgan Healthcare Conference 8:00 a.m. Jan. 9, 2015 - BusinessWire - BZX
Protagen AG Appoints Bernhard Kirschbaum as New Board Member 10:00 a.m. Jan. 8, 2015 - BusinessWire - BZX
Jounce Therapeutics Appoints Deborah Law, D.Phil., to Chief Scientific Officer 9:01 a.m. Jan. 8, 2015 - BusinessWire - BZX
Global Needle-free Drug Delivery Technologies market 2015-2019 2:58 p.m. Jan. 7, 2015 - PR Newswire - PRF
Global Psoriasis Therapeutics Market 2015-2019 2:12 p.m. Jan. 7, 2015 - PR Newswire - PRF
Biotechs to Follow in 2015 off Fresh Insider Moves 10:00 a.m. Jan. 6, 2015 - ACCESSWIRE
HMR Weight Management Services Named No. 2 Best Weight-Loss Diet in U.S. News & World Report's Best Diets of 2015 9:15 a.m. Jan. 6, 2015 - PR Newswire - PRF
Scaling New Heights: Complimentary Research on Stereotaxis, Kite Pharma, ISIS Pharma, Merck and General Motors 8:50 a.m. Jan. 6, 2015 - PR Newswire - PRF
Theralase Anti-Cancer Technology Picks Up Steam 7:00 a.m. Jan. 6, 2015 - ACCESSWIRE
REPEAT - EnWave Signs Non-Exclusive License With Merck, Agrees to Build Second Generation Radiant Energy Vacuum Dryer 9:02 a.m. Jan. 5, 2015 - Marketwired
Merck to Hold Fourth-Quarter and Full-Year 2014 Sales and Earnings Conference Call on February 4 8:00 a.m. Jan. 5, 2015 - BusinessWire - BZX
EnWave Signs Non-Exclusive License With Merck, Agrees to Build Second Generation Radiant Energy Vacuum Dryer 9:01 a.m. Dec. 29, 2014 - Marketwired
Pharmaceuticals, Medicines, Supplements and Drug Manufacturing Industry (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2021, NAIC 325400 8:15 a.m. Dec. 23, 2014 - PR Newswire - PRF
Pipeline Analysis of Hospital Acquired Pneumonia Drugs Market (Tedizolid Phosphate, Ceftolozane/Tazobactam, Ceftazidime/Avibactam, Amikacin Inhale, Plazomicin, and Synflorix) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 202 7:08 a.m. Dec. 23, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Stravito's MCP Server Revolutionizes AI in Business

We're seeing another big swing in how enterprises weave AI into the fabric of decision-making. Stravito, an enterprise customer intelligence platform, launched its Model Context Protocol (MCP) Server. This thing brings company-owned research right into the gizmos teams already use. Now, businesses aren't left groping in the dark figuring out their next moves—pretty...

Quantum Sky's Strategic Leadership Overhaul Targets Growth

Executive Shake-Up Aims for Stronger Federal Market Alignment Buckle up, folks—there's some major chess-piecing happening at Quantum Sky. They've just named not one or two, but three executive bigwigs to head up their core business groups. This isn’t just some ceremonial reshuffle. Nah, it’s bigger. They're redefining how they tackle the Department of War, Intel &...

Retirement Security Faces Global Headwinds in 2026

Grappling with an Uncertain Retirement Future Welcome to the 2026 Global Retirement Index (GRI), where it seems we're all being told to brace for a rough retirement ride. This year's results, crafted by Natixis Investment Managers and their pals at CoreData Research, spotlight just how shaky the ground has gotten. The core troublemakers? Aging populations, whopping public...

NORD Honors Innovators Shaping Rare Disease Treatment

Saluting the Trailblazers in Rare Disease Space Alright, let's cut to it. In a world flooded with more rare diseases than most of us can count, about 10,000 of them, only a measly 5% have any kind of approved treatment. The National Organization for Rare Disorders (NORD) is out here celebrating the folks who dare to change that bleak outlook. With the 2026 Rare Impact...

PostalAnnex Lands at Stanford with New Service Hub

PostalAnnex Makes a Strategic Stanford Move It's not every day you see a company nestling into a place like Stanford University. Annex Brands has just opened its latest PostalAnnex location, a stone’s throw from the academic hustle and bustle of the Stanford campus. The geeky vibe of students and professors rushing with deadlines matches well with the efficient service...

Wrensilva Unveils Studio Console in White Oak

The White Oak Revolution Out of San Diego, Wrensilva's giving audiophiles a new reason to tune in: the Studio record console now comes dressed to impress in White Oak. This marks a fresh chapter in their craftsmanship tale, marrying sleek design with the earthy charm of this beloved hardwood. And guess what? The demand for serene home listening setups is peaking like...

CATL Opens Europe's Largest Battery Service Hub

A New Era for EV Batteries in Norway Stepping into Oslo's tech realm, CATL's grand opening is not just another corporate ribbon-cutting spree. It's a big splash in Europe's battery pool, boasting the largest NING SERVICE center outside of Asia. Here we are, folks, at the crossroads where the EV market meets the nitty-gritty of practical service. Norway's Electric...

Starr Conspiracy Unveils AI Tool for B2B Tech Firms

AI-Driven Insight in Minutes: A Game Changer for B2B Hold onto your hats, because The Starr Conspiracy just lit a fire in the B2B tech world with its latest offering—Battle Card Builder. This free tool cranks out competitive intelligence in no time, literally about four minutes. Geared specifically for B2B tech marketing and sales teams, it combines decades of know-how...

New Podcast by Paralyzed Veterans of America Offers Unique Insights

Empowering Veterans Through Storytelling Some stories don't just rattle around in your headphones—they stick with you. The 'Voices of PVA' podcast, launched by Paralyzed Veterans of America, aims to do exactly that. It's not just a podcast; it's a platform where voices of veterans and people with spinal cord injuries like MS and ALS aren't just heard, they're amplified....

Unicycive's Legal Turmoil: Opportunity for Investor Action

Unicycive's Legal Headache: What's Brewing? Here we go again, folks. If you're holding shares of Unicycive Therapeutics, Inc. (UNCY), buckle up because it's looking like a storm's on the horizon. The Law Offices of Howard G. Smith have dropped the news that shareholders can step up to lead a securities fraud class action lawsuit against the company. That chance to be part...